ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
97,874.33
-0.34%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Essentra Plc (ESNT) Quote

Essentra Plc

Essentra Plc (ESNT)

Essent Group Ltd
130.40
-1.00
(-0.76%)
Closed January 05 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
130.40
Bid
129.80
Ask
130.20
Volume
220,563
129.20 Day's Range 130.60
126.00 52 Week Range 191.20
Market Cap
375.008M
Previous Close
131.40
Open
130.60
Last Trade
105765
@
130.4
(UT)
Last Trade Time
Financial Volume
287,303p
VWAP
130.259
Average Volume (3m)
505,700
Shares Outstanding
287,582,744
Dividend Yield
2.80%
PE Ratio
69.15
Earnings Per Share (EPS)
0.02
Revenue
611.6M
Net Profit
5.4M

About Essentra Plc

Sector
Plastics,resins,elastomers
Industry
Plastics,resins,elastomers
Website
www.essentraplc.com
Headquarters
Oxford, Gbr
Founded
-
Essentra Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker ESNT. The last closing price for Essentra was 131.40p. Over the last year, Essentra shares have traded in a share price range of 126.00p to 191.20p.

Essentra currently has 287,582,744 shares outstanding. The market capitalization of Essentra is £377.88 million. Essentra has a price to earnings ratio (PE ratio) of 69.15.

Ask ADVFN Intelligence (AI)

ESNT Latest News

More News

Essentra plc Total Voting Rights

Essentra plc 02 January 2025   2 January 2025   ESSENTRA PLC   Total Voting Rights       Essentra plc (the Company") announces that in accordance with DTR 5.6.1R of the FCA's Disclosure...

January 02 2025
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 31 December 2024   31 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 30 December 2024 it purchased the...

December 31 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 30 December 2024   30 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 27 December 2024 it purchased the...

December 30 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 24 December 2024   24 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 23 December 2024 it purchased the...

December 24 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 23 December 2024   23 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 20 December 2024 it purchased the...

December 23 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 19 December 2024   19 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 18 December 2024 it purchased the...

December 19 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 17 December 2024   17 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 16 December 2024 it purchased the...

December 17 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 16 December 2024   16 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 13 December 2024 it purchased the...

December 16 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 12 December 2024   12 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 11 December 2024 it purchased the...

December 12 2024
RNS Regulatory News

Essentra plc Transaction in Own Shares

Essentra plc 10 December 2024   10 December 2024 ESSENTRA PLC Transaction in Own Shares Essentra plc ("Essentra", or the "Company") announces that on 09 December 2024 it purchased the...

December 10 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.772797527048129.4133.6128.8199401131.33597517DE
4-18.2-12.2476446837148.6149.6128.4457271137.39210308DE
12-17.2-11.6531165312147.6159.8128.4505700147.12225617DE
26-29.6-18.5160180.8126609290154.0093132DE
52-38.4-22.7488151659168.8191.2126634719162.96365168DE
156-217.1-62.4748201439347.5366126695877202.64737517DE
260-311.8-70.5110809588442.2446.8126596642231.00399108DE

ESNT - Frequently Asked Questions (FAQ)

What is the current Essentra share price?
The current share price of Essentra is 130.40p
How many Essentra shares are in issue?
Essentra has 287,582,744 shares in issue
What is the market cap of Essentra?
The market capitalisation of Essentra is GBP 377.88M
What is the 1 year trading range for Essentra share price?
Essentra has traded in the range of 126.00p to 191.20p during the past year
What is the PE ratio of Essentra?
The price to earnings ratio of Essentra is 69.15
What is the cash to sales ratio of Essentra?
The cash to sales ratio of Essentra is 0.61
What is the reporting currency for Essentra?
Essentra reports financial results in GBP
What is the latest annual turnover for Essentra?
The latest annual turnover of Essentra is GBP 611.6M
What is the latest annual profit for Essentra?
The latest annual profit of Essentra is GBP 5.4M
What is the registered address of Essentra?
The registered address for Essentra is LANGFORD LOCKS, KIDLINGTON, OXFORD, OX5 1HX
What is the Essentra website address?
The website address for Essentra is www.essentraplc.com
Which industry sector does Essentra operate in?
Essentra operates in the PLASTICS,RESINS,ELASTOMERS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
boi568 boi568 7 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 19 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 21 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 23 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 24 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 24 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 25 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 27 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 28 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 29 minutes ago
Not good, thanks for sharing.
sand sand 36 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 36 minutes ago
Moving hard soon 
EFSH
mining101 mining101 38 minutes ago
Superb
MEGL
benz280c benz280c 45 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 51 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 52 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 55 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hour ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hour ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 1 hour ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT

Your Recent History

LSE
ESNT
Essentra
LBNK
POVEUSDT
Proof Of Value Engine
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads